European Journal of Cancer
Volume 46, Issue 9 , Pages 1607-1616, June 2010

Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979–2003

  • Ramandeep S. Arora

      Affiliations

    • Cancer Research UK Paediatric and Familial Cancer Research Group, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PL, UK
    • Corresponding Author InformationCorresponding author: Tel.: +44 161 2751446; fax: +44 161 2755348.
  • ,
  • Robert D. Alston

      Affiliations

    • Cancer Research UK Paediatric and Familial Cancer Research Group, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PL, UK
  • ,
  • Tim O.B. Eden

      Affiliations

    • Academic Unit of Paediatric and Adolescent Oncology, University of Manchester, TCT Young Oncology Unit, Christie Hospital NHS Foundation Trust, Withington, Manchester M20 4BX, UK
  • ,
  • Edward J. Estlin

      Affiliations

    • Paediatric Oncology, Royal Manchester Children’s Hospital, Oxford Road, Manchester M13 9WL, UK
  • ,
  • Anthony Moran

      Affiliations

    • North West Cancer Intelligence Service, Christie Hospital NHS Foundation Trust, Withington, Manchester M20 4BX, UK
  • ,
  • Marco Geraci

      Affiliations

    • Cancer Research UK Paediatric and Familial Cancer Research Group, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PL, UK
  • ,
  • Jillian M. Birch

      Affiliations

    • Cancer Research UK Paediatric and Familial Cancer Research Group, Stopford Building, University of Manchester, Oxford Road, Manchester M13 9PL, UK

Received 29 January 2010; accepted 1 February 2010. published online 02 March 2010.

Abstract 

Reported increases in the incidence of CNS tumours in the developed world in the 1970s to 1990s have been a cause for concern and debate. It still remains to be adequately answered whether these increases are true or an artefact of changes in diagnostic and registration practices. Using high-quality national cancer registration data, we have analysed incidence trends for each major histological subgroup of CNS tumour (2000 World Health Organisation (WHO) classification) registered in those aged 0–84years for the whole of England during the period 1979 through 2003. 134,509 primary CNS tumours of malignant, benign and uncertain behaviour located in the brain, meninges, spinal cord, cranial nerves, other parts of the central nervous system and in the pituitary and pineal glands were registered. In summary, we present the single largest nationwide study on the longitudinal incidence trends of CNS tumours. The increase in incidence observed in the 1970s and 1980s was mainly in the young and the elderly and has now plateaued and may even be decreasing. There is however variation in trends by histology. The incidence of some histological sub-groups has continued to increase until the most recent period of analysis. Much of the initial increase can be attributed to the emergence of much more widely available neuroimaging, while the most recent incidence changes for specific sub-groups of CNS tumours appear to be due to greater diagnostic specificity leading to a shift in registered categories. However, the trends for high-grade astrocytomas and other gliomas need further observation and investigation.

Keywords: Central nervous system tumours, Tumour incidence, Longitudinal trends, Cancer registry, England

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0959-8049(10)00110-3

doi:10.1016/j.ejca.2010.02.007

European Journal of Cancer
Volume 46, Issue 9 , Pages 1607-1616, June 2010